Previous symbols: C1orf4, SMARCF1. Aliases: B120, P270, C10rf4, BAF250, BAF250a.
ARID1A (BAF250A/p270) is a nuclear DNA-binding and assembly subunit of canonical mammalian SWI/SNF (cBAF) chromatin-remodeling complexes. Its ARID domain binds DNA without an established AT-rich sequence preference, while other regions associate with complex components and transcriptional regulators. ARID1A-containing complexes couple substrate engagement and regulatory recruitment to ATP-driven nucleosome remodeling by SMARCA4 or SMARCA2, supporting context-dependent transcriptional activation and repression. ARID1A and ARID1B occupy alternative positions in cBAF assemblies. ARID1A also participates in TOP2A-associated chromosome decatenation and contributes to developmental gene-regulatory programs; altered ARID1A function is associated with developmental disorders and cancer.
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| Adenomyosis | somatic driver | |
| Endometriosis | somatic driver somatic | |
| Gastric Adenocarcinoma | somatic driver somatic |
mechanism: EBV-Driven Hypermethylation and Checkpoint Ligand Amplification
scoped to subtype: EBV-positive
|
| Salivary Gland Polymorphous Adenocarcinoma | cooperating somatic |
mechanism: PRKD Family Gene Rearrangement
|
| Chordoma |
untyped
Somatic Epigenetic Dysregulation
|
|
| Clear Cell Ovarian Carcinoma |
untyped
Recurrent tumor suppressor mutation with frequent biallelic loss
|
|
| Coffin-Siris syndrome |
untyped
Causative
|
mechanism: BAF/SWI-SNF chromatin remodeling dysfunction; Cardiac neural crest dysregulation from BAF dysfunction; Cranial neural crest specification defect from ARID1A-BAF/ZIC2 axis; Mesenchymal stem cell quiescence loss and tooth root progenitor defects
subtype: CSS2
scoped to subtype: CSS2
|
| EBV-Associated Gastric Cancer |
untyped
Somatic Mutation
|
|
| Endometrial Endometrioid Adenocarcinoma |
untyped
Recurrent somatic chromatin remodeling driver alteration
somatic
|
|
| Gallbladder Cancer |
untyped
Somatic Loss-of-Function Mutation
|
|
| Gastric Cancer H. pylori Associated |
untyped
Somatic Mutations
|
|
| Hepatocellular Carcinoma |
untyped
Somatic Loss of Function
|
|
| IDH-Mutant Cholangiocarcinoma |
untyped
Co-occurring Mutations
|
|
| Ovarian Endometrioid Carcinoma |
untyped
Loss-of-function mutation
|
mechanism: ARID1A and SWI/SNF Chromatin Remodeling Loss
|
| Sezary Syndrome |
untyped
Tumor Suppressor Loss
|
|
| Transitional Cell Carcinoma | untyped somatic | |
| Endometrial Carcinoma | no genetic record |
mechanism: PTEN PI3K Pathway Dysregulation
|
An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.
| ClinGen disease | MOI | Classification | dismech entry |
|---|---|---|---|
| Coffin-Siris syndrome MONDO:0015452 | AD | Definitive 2021-07-07 |
Coffin-Siris syndrome
untyped
|
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.